Literature DB >> 12412865

Association of cytokine responses with disease severity in infants with respiratory syncytial virus infection.

Z M Chen1, J H Mao, L Z Du, Y M Tang.   

Abstract

AIM: To explore the relationship between cytokine responses and severity of respiratory syncytial virus (RSV) infection in infants.
METHODS: Intracellular interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) expression in peripheral blood CD3+ and CD8+ lymphocytes was measured by four-colour flow cytometry. Serum IL-12, IL-4 and IFN-gamma levels were also determined by enzyme-linked immunosorbent assay.
RESULTS: The frequency of IL-4 and IFN-gamma expression in CD3+CD8- cells was the same in RSV-infected, non-RSV-infected and control infants and in those with RSV bronchiolitis or RSV pneumonia, indicating that no Th2 predominance exists in the acute phase of RSV infection and RSV bronchiolitis. Furthermore, RSV-infected infants had a more frequent IFN-gamma expression in CD3+CD8+ cells than controls, and they also showed a much lower serum IL-4/ IFN-gamma ratio because of decreased IL-4 and elevated IFN-gamma, the latter being most prominent in RSV bronchiolitis. The serum IL-12 level in RSV-infected infants was the same as in control infants, while those with non-RSV infections had a much higher level. Serum IL-12, IFN-gamma and frequency of IFN-gamma expression in CD3+CD8+ cells in mild RSV infection were much higher than in controls, while no difference existed between severe cases and controls.
CONCLUSION: Type 2 cytokine predominance was not found in the acute phase of RSV infection and RSV bronchiolitis, but both were accompanied by enhanced production of IFN-gamma and a much higher serum IFN-gamma level than in healthy controls, especially in those with RSV bronchiolitis, suggesting a role in causing airway obstruction. IFN-gamma and IL-12 may also play a protective role in RSV infections by diminishing viral replication, and high levels of IL-12 and IFN-gamma may be associated with lessening of the severity of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412865     DOI: 10.1080/080352502760272588

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  15 in total

1.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

2.  Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis.

Authors:  Luan D Vu; David Siefker; Tamekia L Jones; Dahui You; Ryleigh Taylor; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

Review 3.  New insights for development of a safe and protective RSV vaccine.

Authors:  Jorge C G Blanco; Marina S Boukhvalova; Kari Ann Shirey; Gregory A Prince; Stefanie N Vogel
Journal:  Hum Vaccin       Date:  2010-06-01

Review 4.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

5.  Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells.

Authors:  Christine M Oshansky; James P Barber; Jackelyn Crabtree; Ralph A Tripp
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

6.  Cell-mediated immune responses to respiratory syncytial virus infection: magnitude, kinetics, and correlates with morbidity and age.

Authors:  Bessey Geevarghese; Adriana Weinberg
Journal:  Hum Vaccin Immunother       Date:  2014-02-10       Impact factor: 3.452

7.  Production and differentiation of myeloid cells driven by proinflammatory cytokines in response to acute pneumovirus infection in mice.

Authors:  Steven Maltby; Nicole G Hansbro; Hock L Tay; Jessica Stewart; Maximilian Plank; Bianca Donges; Helene F Rosenberg; Paul S Foster
Journal:  J Immunol       Date:  2014-09-08       Impact factor: 5.422

8.  Cutting edge: lack of high affinity competition for peptide in polyclonal CD4+ responses unmasks IL-4 production.

Authors:  Joshua D Milner; Nicolas Fazilleau; Michael McHeyzer-Williams; William Paul
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

Review 9.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

10.  Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.

Authors:  Fengmin Zhou; Amanda Goodsell; Yasushi Uematsu; Michael Vajdy
Journal:  Clin Vaccine Immunol       Date:  2009-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.